HCPLive Network

Product News

As it continues to tackle the issue of prescription drug abuse, the US Food and Drug Administration today approved an extended-release/long-acting opioid analgesic designed to help chronic pain patients while curbing their ability to tamper it.
A wearable device for managing diabetic peripheral neuropathy has been cleared by the US Food and Drug Administration.
In 2 recent clinical trials, a treatment for young patients diagnosed with attention deficit hyperactivity disorder reportedly demonstrated benefit over another currently used ADHD medication.
The US Food and Drug Administration recently approved a new drug aimed to aid the thousands of Americans affected by hereditary angioedema.
A new drug has been designated a Qualified Infectious Disease Product by the US Food and Drug Administration to treat patients diagnosed with invasive candidiasis.
In an effort to help patients diagnosed with mild-to-moderate Alzheimer’s disease, drug manufacturer Roche announced the results of a pair of clinical studies on its investigational medication, crenezumab.
The US Food and Drug Administration recently announced its approval of a new medication for the treatment of rheumatoid arthritis.
The Food and Drug Administration (FDA) has announced the approval of a new medication aimed at helping the nearly 26 million people in the country with diabetes.
Preliminary results from a University of Pennsylvania study show the stimulant Vyvanse (lisdexamfetamine dimesylate) improves memory lapses in postmenopausal women.
$AD300x250BB$